Emitefur
Emitefur is an orally active and potent anticancer drug. Emitefur can be used for advanced gastric cancer patients[1].
Product Specifications
CAS Number
110690-43-2
Product Name Alternative
BOF-A2
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emitefur.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC(C(N(C2=O)C(N(C=C2F)COCC)=O)=O)=C1)OC3=NC(OC(C4=CC=CC=C4)=O)=CC=C3C#N
Molecular Formula
C28H19FN4O8
Molecular Weight
558.47
References & Citations
[1]Sugimachi K, et al. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer. Surg Today. 2000;30 (12) :1067-72.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FKLF / KLF11 (KLF11) Mouse Monoclonal Antibody [Clone ID: OTI3G4]](https://cdn.genprice.uk/products/937/68dd18bb061270361e9089f8/imageurl/cf810999.webp)
CF810999 100 µg
FKLF / KLF11 (KLF11) Mouse Monoclonal Antibody [Clone ID: OTI3G4]
Sign In for Pricing
View Details 
![N-[(2E)-3-(4-Hydroxyphenyl)-1-oxo-2-propen-1-yl]-L-aspartic Acid](https://cdn.genprice.uk/products/572/4879897236633/imageurl/trc-h899980-50mg.webp)
TRC-H899980-50MG 50 mg
N-[(2E)-3-(4-Hydroxyphenyl)-1-oxo-2-propen-1-yl]-L-aspartic Acid
Sign In for Pricing
View Details 
BNC682741-100 1x 100 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940755-500 1x 500 µL
Human Kappa Light Chain (HP6053 + L1C1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details